All In Biotech

Free tool

FAERS Monitor: Famotidine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 219935 or its brand name (Famotidine, Famotidine). Reports on generic versions are filed under their own applications.

Reports

78,942

Serious

53,278

67% of reports

Hospitalization

27,214

Death reported

7,746

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea5,149
  • fatigue4,939
  • diarrhoea4,819
  • off label use4,129
  • dyspnoea3,819
  • drug ineffective3,758
  • chronic kidney disease3,530
  • headache3,502
  • vomiting3,144
  • pain3,086
  • dizziness2,919
  • acute kidney injury2,806
  • death2,721
  • pneumonia2,666
  • pyrexia2,620

Reports by year received

View as table
YearReports
2004678
2005672
2006635
2007628
2008800
2009663
2010963
20111,476
20121,834
20131,084
20141,359
20152,195
20162,700
20173,026
20184,037
20194,683
20206,218
20216,355
20226,923
20237,023
20248,242
20259,224
20267,520

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,975,217 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal3,53012.912.537,182
acute kidney injurySignal2,8065.04.88,763
pneumoniaSignal2,6662.22.11,765
pyrexiaSignal2,6202.02.01,371
diarrhoea4,8192.01.92,453
dyspnoea3,8191.81.71,393
vomiting3,1441.81.71,106
nausea5,1491.71.71,666
fatigue4,9391.71.61,450
dizziness2,9191.61.5601
headache3,5021.51.4580
pain3,0861.31.3273
off label use4,1291.31.2226
death2,7210.80.885
drug ineffective3,7580.80.7306

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.